Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SOPHiA GENETICS (SOPH) Change in Intangibles (2020 - 2025)

Historic Change in Intangibles for SOPHiA GENETICS (SOPH) over the last 6 years, with Q3 2025 value amounting to -$136000.0.

  • SOPHiA GENETICS's Change in Intangibles fell 38571.43% to -$136000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$223000.0, marking a year-over-year decrease of 13878.26%. This contributed to the annual value of -$195000.0 for FY2024, which is 2585.55% up from last year.
  • According to the latest figures from Q3 2025, SOPHiA GENETICS's Change in Intangibles is -$136000.0, which was down 38571.43% from -$41000.0 recorded in Q2 2025.
  • Over the past 5 years, SOPHiA GENETICS's Change in Intangibles peaked at $1.0 million during Q4 2022, and registered a low of -$675000.0 during Q2 2022.
  • Its 5-year average for Change in Intangibles is -$70833.3, with a median of -$62500.0 in 2021.
  • The largest annual percentage gain for SOPHiA GENETICS's Change in Intangibles in the last 5 years was 5155000.0% (2022), contrasted with its biggest fall of 954285.71% (2022).
  • Over the past 5 years, SOPHiA GENETICS's Change in Intangibles (Quarter) stood at $2000.0 in 2021, then soared by 51550.0% to $1.0 million in 2022, then decreased by 25.46% to $770000.0 in 2023, then tumbled by 103.64% to -$28000.0 in 2024, then tumbled by 385.71% to -$136000.0 in 2025.
  • Its last three reported values are -$136000.0 in Q3 2025, -$41000.0 for Q2 2025, and -$46000.0 during Q1 2025.